Pages that link to "Q46433363"
Jump to navigation
Jump to search
The following pages link to Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients (Q46433363):
Displaying 50 items.
- Estrogen receptor {beta}1 expression is regulated by miR-92 in breast cancer (Q24595552) (← links)
- Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer (Q26773907) (← links)
- Clinical significance of estrogen receptor β in breast and prostate cancer from biological aspects (Q28087001) (← links)
- Expression of oestrogen receptors, ERalpha, ERbeta, and ERbeta variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha (Q33503908) (← links)
- ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR (Q33739387) (← links)
- Assessment of automated image analysis of breast cancer tissue microarrays for epidemiologic studies (Q33781177) (← links)
- Estrogen Receptor β (Q33785182) (← links)
- Gender effect in experimental models of human medulloblastoma: does the estrogen receptor β signaling play a role? (Q33856461) (← links)
- Breast Cancer Reporting in Lagos, Nigeria: Implications for Training and Education in Africa (Q33859652) (← links)
- Somatic loss of estrogen receptor beta and p53 synergize to induce breast tumorigenesis (Q33864656) (← links)
- Estrogen Receptor-β and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer. (Q33866151) (← links)
- Phosphorylation of estrogen receptor beta at serine 105 is associated with good prognosis in breast cancer (Q34086835) (← links)
- Oestrogen receptors β1 and βcx have divergent roles in breast cancer survival and lymph node metastasis (Q34113589) (← links)
- ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches (Q34119028) (← links)
- ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer (Q34334131) (← links)
- Estrogen as Jekyll and Hyde: regulation of cell death (Q34570235) (← links)
- Clinical significance of the nuclear receptor co-regulator DC-SCRIPT in breast cancer: an independent retrospective validation study. (Q34613612) (← links)
- Estrogen receptor-beta expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study (Q34663257) (← links)
- Potent genistein derivatives as inhibitors of estrogen receptor alpha-positive breast cancer (Q35050479) (← links)
- ERβ1 represses FOXM1 expression through targeting ERα to control cell proliferation in breast cancer (Q35168154) (← links)
- Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer (Q35218145) (← links)
- Biologic roles of estrogen receptor-β and insulin-like growth factor-2 in triple-negative breast cancer (Q35271188) (← links)
- Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen (Q35558946) (← links)
- Down-Regulation of miR-92 in Breast Epithelial Cells and in Normal but Not Tumour Fibroblasts Contributes to Breast Carcinogenesis (Q35799412) (← links)
- PKCα and ERβ Are Associated with Triple-Negative Breast Cancers in African American and Caucasian Patients (Q35821415) (← links)
- Altered expression of estrogen receptor β2 is associated with different biological markers and clinicopathological factors in papillary thyroid cancer (Q35919319) (← links)
- Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis (Q35931634) (← links)
- Phosphorylation of human estrogen receptor-beta at serine 105 inhibits breast cancer cell migration and invasion. (Q38636502) (← links)
- Estrogen receptor-beta and breast cancer: translating biology into clinical practice (Q35973424) (← links)
- Prognostic significance of full-length estrogen receptor beta expression in stage I-III triple negative breast cancer. (Q35993074) (← links)
- PES1 promotes breast cancer by differentially regulating ERα and ERβ (Q36129096) (← links)
- ERβ expression and breast cancer risk prediction for women with atypias (Q36248899) (← links)
- Estrogen receptors β1 and β2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3. (Q36454557) (← links)
- Estrogen receptors and human disease: an update (Q36661810) (← links)
- Involvement of estrogen receptor β5 in the progression of glioma (Q36822938) (← links)
- Estrogen receptor beta as a prognostic factor in breast cancer patients: A systematic review and meta-analysis (Q36962972) (← links)
- ERβ decreases the invasiveness of triple-negative breast cancer cells by regulating mutant p53 oncogenic function (Q37046414) (← links)
- Development, characterization, and applications of a novel estrogen receptor beta monoclonal antibody (Q37049590) (← links)
- The cervical malignant cells display a down regulation of ER-α but retain the ER-β expression (Q37054568) (← links)
- Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression (Q37169705) (← links)
- Differential regulation of oestrogen receptor β isoforms by 5' untranslated regions in cancer (Q37294996) (← links)
- Deregulation of IGF-binding proteins -2 and -5 contributes to the development of endocrine resistant breast cancer in vitro (Q37362627) (← links)
- Estrogen receptor β isoform 5 confers sensitivity of breast cancer cell lines to chemotherapeutic agent-induced apoptosis through interaction with Bcl2L12. (Q37382513) (← links)
- Lapatinib induces p27(Kip1)-dependent G₁ arrest through both transcriptional and post-translational mechanisms (Q37396923) (← links)
- Recent perspectives of breast cancer prognosis and predictive factors (Q37407119) (← links)
- Overview of diagnostic/targeted treatment combinations in personalized medicine for breast cancer patients. (Q37444430) (← links)
- Support of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cells (Q37624907) (← links)
- Smoking out reproductive hormone actions in lung cancer (Q37679479) (← links)
- Post-transcriptional regulation of human breast cancer cell proteome by unliganded estrogen receptor β via microRNAs (Q37687422) (← links)
- Characterisation of male breast cancer: a descriptive biomarker study from a large patient series (Q37723938) (← links)